Zobrazeno 1 - 10
of 41
pro vyhledávání: '"S, Geiser"'
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 7, Pp 1214-1223 (2024)
Abstract The objective was to characterize the pharmacokinetics (PK) and pharmacodynamics (PD) of glucagon after injectable or nasal administration and confirm the appropriate therapeutic dose of nasal glucagon (NG) for adult patients. Six clinical s
Externí odkaz:
https://doaj.org/article/da041c0a1a8748d591c4fd28f38d0670
Publikováno v:
Clinical Pharmacokinetics. 56:1415-1427
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for the treatment of type 2 diabetes mellitus are known to delay gastric emptying (GE). The potential effect of the GLP-1 RA dulaglutide on the pharmacokinetics (PK) of four orally administered dr
Autor:
Eric J. Bush, A.M. Pelzel-McCluskey, L.H. Creekmore, S. Geiser-Novotny, A.M. Wiedenheft, J.L. Traub-Dargatz, T.R. Kasari, K.E. Bjork
Publikováno v:
Journal of Veterinary Internal Medicine. 27:339-346
Background A large multistate outbreak of equine herpesvirus myeloencephalopathy (EHM) occurred in May 2011 among horses that participated in a competitive event. Objective To identify EHM risk factors among horses with a common exposure venue. Anima
Publikováno v:
Equine Veterinary Journal. 42:220-227
Summary Reason for performing study: Older horses have an increased risk of hyperthermia due to impaired cardiovascular function. While many studies have investigated thermoregulation in horses during exercise, none have investigated the effects of a
Publikováno v:
Equine Veterinary Journal. 34:524-531
Summary The purpose of the present study was to determine whether the training-induced hypervolemic response seen in the horse is associated with aldosterone-mediated renal mechanisms affecting sodium conservation during the first days of training. F
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jenny Y. Chien, Michael Heathman, Xuewei Cui, Amparo de la Peña, Corina Loghin, Jeanne S. Geiser, Jennifer A. Martin
Publikováno v:
Clinical pharmacokinetics. 55(5)
Dulaglutide is a long-acting glucagon-like peptide-1 receptor agonist administered as once-weekly subcutaneous injections for the treatment of type 2 diabetes (T2D). The clinical pharmacokinetics of dulaglutide were characterized in patients with T2D
Publikováno v:
Equine veterinary journal. Supplement. (38)
Older horses have an increased risk of hyperthermia due to impaired cardiovascular function. While many studies have investigated thermoregulation in horses during exercise, none have investigated the effects of ageing.To test the hypothesis that the
Publikováno v:
Equine veterinary journal. Supplement. (36)
Summary Reasons for performing study: Recombinant human erythropoietin (rhuEPO) causes an increase in red blood cell production and aerobic capacity in other species; however, data are lacking on effects in the horse. Hypothesis: This study tested th
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.